Bdr Pharmaceuticals

Bdr Pharmaceuticals company information, Employees & Contact Information

Established in 2002 into API manufacturing, we have a consolidated position in the domestic and global market for the API Business. In today’s dynamic global pharmaceutical market, we at BDR Pharmaceuticals have carved a niche for ourselves, with our formulations portfolio for specialty medication. Our unique strategy of multi-branding ensures that critical and lifesaving medicines are available at affordable prices with two API and formulation facilities at Gujarat, Uttarakhand and a pellet facility at Hyderabad.

Company Details

Employees
329
Address
Mumbai, In
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Engineer jobs.
HQ
Mumbai
Looking for a particular Bdr Pharmaceuticals employee's phone or email?

Bdr Pharmaceuticals Questions

News

BDR Pharma targeting 2027 for IPO launch, looking to acquire units in US, says CMD Dharmesh Shah - Moneycontrol

BDR Pharma targeting 2027 for IPO launch, looking to acquire units in US, says CMD Dharmesh Shah Moneycontrol

BDR Pharma receives Rs. 685 crore of PE investment - Indian Pharma Post

BDR Pharma receives Rs. 685 crore of PE investment Indian Pharma Post

Remdesivir manufacturer BDR Pharma raises Rs 685 Cr at a valuation of $95M - YourStory.com

Remdesivir manufacturer BDR Pharma raises Rs 685 Cr at a valuation of $95M YourStory.com

BDR Pharma raises Rs 685 crore from multiples, other investors - The Economic Times

BDR Pharma raises Rs 685 crore from multiples, other investors The Economic Times

BDR Pharma Raises INR 685 Crore From Multiples, Other Investors - Entrepreneur India

BDR Pharma Raises INR 685 Crore From Multiples, Other Investors Entrepreneur India

Multiples PE-led consortium invests $88 mn in BDR Pharma - Mint

Multiples PE-led consortium invests $88 mn in BDR Pharma Mint

BDR Pharma signs voluntary licensing agreement with Lilly for baricitinib - Express Pharma

BDR Pharma signs voluntary licensing agreement with Lilly for baricitinib Express Pharma

BDR Pharma launches world's first Enzalutamide oral solution for prostate cancer treatment - BioSpectrum India

BDR Pharma launches world's first Enzalutamide oral solution for prostate cancer treatment BioSpectrum India

BDR Pharma launches generic drug for fungal infections at 1/3rd the cost - Business Standard

BDR Pharma launches generic drug for fungal infections at 1/3rd the cost Business Standard

BDR Pharma launches prostrate cancer drug in oral solution form - BusinessLine

BDR Pharma launches prostrate cancer drug in oral solution form BusinessLine

BDR Pharma, Varenyam launch Sugammadex anaesthesia drugs in India - ET HealthWorld

BDR Pharma, Varenyam launch Sugammadex anaesthesia drugs in India ET HealthWorld

BDR Pharma launches BDENZA 160 mg for treatment of Prostate Cancer - financialexpress.com

BDR Pharma launches BDENZA 160 mg for treatment of Prostate Cancer financialexpress.com

Remdesivir maker BDR Pharma eyes IPO, India MSME Summit is back, and other top SMB stories of the week - YourStory.com

Remdesivir maker BDR Pharma eyes IPO, India MSME Summit is back, and other top SMB stories of the week YourStory.com

BDR Pharma CMD’s family buys luxury apartments in Mumbai’s Worli for Rs 81 cr - The Economic Times

BDR Pharma CMD’s family buys luxury apartments in Mumbai’s Worli for Rs 81 cr The Economic Times

BDR Pharma launches generic Palbociclib for breast cancer treatment - Express Pharma

BDR Pharma launches generic Palbociclib for breast cancer treatment Express Pharma

Multiples PE-led consortium to buy 9.3% in BDR Pharma for Rs 685 crore - Moneycontrol

Multiples PE-led consortium to buy 9.3% in BDR Pharma for Rs 685 crore Moneycontrol

BDR Pharma inks license agreement with DRDO to produce COVID-19 drug 2-DG - The Economic Times

BDR Pharma inks license agreement with DRDO to produce COVID-19 drug 2-DG The Economic Times

BDR Pharma launches generic antibiotic range medicine, Ceftazidime Avibactum - Express Pharma

BDR Pharma launches generic antibiotic range medicine, Ceftazidime Avibactum Express Pharma

Multiples Alternate buys into BDR Pharma, invests Rs 750 cr - The Economic Times

Multiples Alternate buys into BDR Pharma, invests Rs 750 cr The Economic Times

BDR Pharma launches Dalbonova Injection for acute bacterial skin infections - Express Pharma

BDR Pharma launches Dalbonova Injection for acute bacterial skin infections Express Pharma

Mumbai real estate update: BDR Pharma promoter purchases 2 apartments worth Rs 80 crore in Worli - Moneycontrol

Mumbai real estate update: BDR Pharma promoter purchases 2 apartments worth Rs 80 crore in Worli Moneycontrol

BDR Pharma in limelight after taking on MNCs - Business Standard

BDR Pharma in limelight after taking on MNCs Business Standard

Top Bdr Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant